Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
about
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Sorafenib promotes graft-versu ...... LT3-ITD-mutant leukemia cells.
@en
Sorafenib promotes graft-versu ...... LT3-ITD-mutant leukemia cells.
@nl
type
label
Sorafenib promotes graft-versu ...... LT3-ITD-mutant leukemia cells.
@en
Sorafenib promotes graft-versu ...... LT3-ITD-mutant leukemia cells.
@nl
prefLabel
Sorafenib promotes graft-versu ...... LT3-ITD-mutant leukemia cells.
@en
Sorafenib promotes graft-versu ...... LT3-ITD-mutant leukemia cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Sorafenib promotes graft-versu ...... FLT3-ITD-mutant leukemia cells
@en
P2093
Andrea S Henden
Andrea Schmidts
Andreas Burchert
Andreas Hochhaus
Andreas Neubauer
Anita Sarma
Anna L Illert
Annette Schmitt-Graeff
Antonia M Müller
Arnim Weber
P2860
P2888
P304
P356
10.1038/NM.4484
P407
P50
P577
2018-02-12T00:00:00Z